TOMM5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.705400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.425000E-01
Normal-vs-Stage2
5.531400E-01
Normal-vs-Stage3
5.517400E-01
Normal-vs-Stage4
3.109400E-01
Stage1-vs-Stage2
8.371800E-01
Stage1-vs-Stage3
9.531200E-01
Stage1-vs-Stage4
7.202800E-01
Stage2-vs-Stage3
8.080600E-01
Stage2-vs-Stage4
5.918000E-01
Stage3-vs-Stage4
8.643000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.820400E-01
Normal-vs-AfricanAmerican
5.325000E-01
Normal-vs-Asian
3.728600E-01
Caucasian-vs-AfricanAmerican
8.195000E-01
Caucasian-vs-Asian
5.038200E-01
AfricanAmerican-vs-Asian
5.650600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.261000E-01
Normal-vs-Female
4.128800E-01
Male-vs-Female
4.259000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.492640E-01
Normal-vs-Age(41-60Yrs)
4.200000E-01
Normal-vs-Age(61-80Yrs)
5.066600E-01
Normal-vs-Age(81-100Yrs)
2.419000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.888560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.109000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.716400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.802800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.754000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.393800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.091400E-01
Normal-vs-Daily Drinker
5.971800E-01
Normal-vs-Weekly Drinker
4.049800E-02
Normal-vs-Occasional Drinker
6.567700E-02
Normal-vs-Social Drinker
3.148400E-01
Non Drinker-vs-Daily Drinker
5.292600E-01
Non Drinker-vs-Weekly Drinker
7.312200E-02
Non Drinker-vs-Occasional Drinker
1.313030E-01
Non Drinker-vs-Social Drinker
4.728200E-02
Daily Drinker-vs-Weekly Drinker
1.476620E-01
Daily Drinker-vs-Occasional Drinker
2.753800E-01
Daily Drinker-vs-Social Drinker
1.621610E-01
Weekly Drinker-vs-Occasional Drinker
6.562200E-01
Weekly Drinker-vs-Social Drinker
7.462800E-01
Occasional Drinker-vs-Social Drinker
8.883600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.755400E-01
Normal-vs-Grade 2
8.753000E-01
Normal-vs-Grade 3
8.223000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.997800E-01
Grade 1-vs-Grade 3
2.959600E-01
Grade 1-vs-Grade 4
8.755400E-01
Grade 2-vs-Grade 3
1.404980E-01
Grade 2-vs-Grade 4
8.753000E-01
Grade 3-vs-Grade 4
8.223000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.638400E-01
Normal-vs-NonDiabetic
4.221600E-01
Diabetic-vs-NonDiabetic
3.909000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.631400E-01
Normal-vs-NoPancreatitis
4.509000E-01
Pancreatitis-vs-NoPancreatitis
1.237190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.059000E-01
Normal-vs-N1
5.326600E-01
N0-vs-N1
1.530030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.229760E-02
Normal-vs-TP53-NonMutant
7.019600E-02
TP53-Mutant-vs-TP53-NonMutant
2.629200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
